Cited by 379Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease

Du Yan, Shi, Fu, Jin, Soto, Claudio, Chen, Xi, Zhu, Huaijie, Al-Mohanna, Futwan, Collison, Kate, Zhu, Aiping +6 more·1997·Nature

Abstract

Amyloid-beta is a neurotoxic peptide which is implicated in the pathogenesis of Alzheimer's disease. It binds an intracellular polypeptide known as ERAB, thought to be a hydroxysteroid dehydrogenase enzyme, which is expressed in normal tissues, but is overexpressed in neurons affected in Alzheimer's disease. ERAB immunoprecipitates with amyloid-beta, and when cell cultures are exposed to amyloid-beta, ERAB inside the cell is rapidly redistributed to the plasma membrane. The toxic effect of amyloid-beta on these cells is prevented by blocking ERAB and is enhanced by overexpression of ERAB. By interacting with intracellular amyloid-beta, ERAB may therefore contribute to the neuronal dysfunction associated with Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1038/39522

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 48 · Cited by 379

Authors
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., Tohyama, M., Ogawa, S., Roher, A., & Stern, D.
Affiliations
  • Columbia University (US)
  • NYU Langone Health (US)
  • King Faisal Specialist Hospital & Research Centre (SA)
  • Tokyo Metropolitan Institute of Medical Science (JP)
  • The University of Osaka (JP)
  • Banner Sun Health Research Institute (US)
Venue
Nature
Published
1997-10
Volume
389
Issue
6652
Pages
689-695
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2117037463
Cited by
379
References
48
Citations by year
2026: 3 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 7 · 2021: 3 · 2020: 13 · 2019: 10 · 2018: 13 · 2017: 7 · 2016: 11 · 2015: 9 · 2014: 10 · 2013: 7 · 2012: 12
FWCI
14.07
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
ERAB: The European Foundation for Alcohol Research
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
amyloid-beta, Alzheimer's disease, hydroxysteroid dehydrogenase, neurotoxicity, neuronal dysfunction, amyloid-beta toxicity
MeSH terms
Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Carrier Proteins, Cloning, Molecular, HeLa Cells, Humans, Hydroxysteroid Dehydrogenases, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Transfection, 3-Hydroxyacyl CoA Dehydrogenases, Amyloid beta-Peptides, COS Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review